OZEM
Roundhill GLP-1 & Weight Loss ETFOZEM
OZEM
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
11,013% more call options, than puts
Call options by funds: $889K | Put options by funds: $8K
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
11% more funds holding
Funds holding: 9 [Q2] → 10 (+1) [Q3]
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
7.08% less ownership
Funds ownership: 15.21% [Q2] → 8.13% (-7.08%) [Q3]
18% less capital invested
Capital invested by funds: $4.5M [Q2] → $3.7M (-$795K) [Q3]
Research analyst outlook
We haven’t received any recent analyst ratings for OZEM.
Financial journalist opinion
Positive
ETF Trends
1 month ago
Disruptive Theme of the Week – Breakthroughs in Medicine
Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakthroughs and developments and explore a few ways to get actionable exposure to them with ETFs.
Positive
ETF Trends
1 month ago
Disruptive Theme of the Week: Happy Post-Election Themes
With the completion of a close presidential election, roughly half of us are likely disappointed regardless of the winner. To counter the post-election blues, I identified some “happy” ETF themes to consider for investment.
Positive
Zacks Investment Research
3 months ago
Tap the Weight-Loss Drug Market With These ETFs
Investors seeking to tap the boom in weight-loss drug treatment could consider these ETFs.
Neutral
CNBC Television
3 months ago
Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch
Dave Mazza, Roundhill Investments CEO, joins CNBC's Bob Pisani on “Halftime Report's” “ETF Edge” segment to discuss the firms' three ETFs following the Mag7, AI and GLP-1 themes.
Neutral
ETF Trends
4 months ago
Disruptive Theme of the Week: Playing Defense
When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.
Positive
Zacks Investment Research
5 months ago
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment
Two companies, Eli Lilly (LLY) and Novo Nordisk (NVO), have so far dominated the weight-loss drug market. Now, Roche recently announced encouraging Phase I trial data for its new obesity drug candidate.
Positive
ETF Trends
5 months ago
Top Themes in the First Half of 2024: Crypto, Chips, Ships & Silver
After a torrid risk-on run in the first quarter of 2024, markets cooled off a bit but ended the half still positive with mid-double-digit returns. Technology themes such as cryptocurrency and artificial intelligence helped propel markets higher.
Negative
Investopedia
5 months ago
Why Investors Haven't Feasted on Two New Weight-Loss ETFs
Two new weight-loss exchange-traded funds (ETFs) launched in May have yet to whet investors' appetite, possibly due to their expensive fees and concentrated bets.
Positive
Schwab Network
6 months ago
OZEM: Investing in the Weight Loss Craze
Roundhill Investments launched its GLP-1 and Weight Loss ETF (OZEM) on May 21st. Dave Mazza discusses investing in the weight loss craze.
Positive
InvestorPlace
6 months ago
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF
As weight loss drugs are gaining popularity a new way to invest in the companies behind these products has launched with the Roundhill GLP 1 And Weight Loss ETF (NASDAQ:OZEM). Let's get into everything investors need to know about this new weight loss exchange-traded fund (ETF) before investing in OZEM stock below!
Charts implemented using Lightweight Charts™